跳至主要内容
临床试验/CTRI/2013/07/003843
CTRI/2013/07/003843已完成3 期

Safety, Feasibility And Effectiveness Of Oral Zonisamide Monotherapy In Comparison With Intramuscular Adrenocorticotropic Hormone In Treatment Naïve Infants With West Syndrome: A Preliminary Study

PGIMER0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
PGIMER
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosis of West syndrome by clinical assessment and EEG

排除标准

  • 1.Suspected or proven cases of tuberous sclerosis
  • 2.Suspected or proven neurometabolic disease, degenerative brain disease and any progressive neurologic disease other than West syndrome
  • 3.Previous treatment (within 28 days) with or a known contraindication to ACTH or zonisamide treatment
  • 4.Inability of parents or guardians to give informed signed consent
  • 5.Inability of parents or guardians to provide data of outcome as when spasms stop / Inability to come for follow-up

研究者

发起方
PGIMER

相似试验